Literature DB >> 3967924

Lysozyme-mediated aggregation and lysis of the periodontal microorganism Capnocytophaga gingivalis 2010.

V J Iacono, S M Zove, B L Grossbard, J J Pollock, D H Fine, L S Greene.   

Abstract

The ability of lysozyme to aggregate and lyse the gram-negative capnophilic periodontal microorganism Capnocytophaga gingivalis 2010 was monitored optically at 540 nm. Both hen egg white and chromatographically purified human lysozymes had significant but similar aggregation potentials for both logarithmic- and stationary-phase bacteria. In general, an increase in enzyme concentration resulted in a graded increase in both the initial and maximum changes in turbidity which occurred during the reaction period. The greatest change in turbidity occurred within the initial minutes of interaction of lysozyme and the cells, and the extent of aggregation paralleled a rapid depletion of lysozyme by the suspensions during the first minute of its incubation with the bacteria. Interestingly, the muramidase inhibitors N-acetyl-D-glucosamine and histamine did not block aggregation, whereas maleylation of lysozyme completely inhibited its aggregating ability. Demaleylation, however, restored aggregation activity comparable to the native enzyme, indicating that maleylated lysozyme retained its integrity and that aggregation was primarily dependent on charge. The addition of up to physiological concentrations of NaHCO3 and NaCl to cell aggregates resulted in varying degrees of deaggregation and lysis. Surprisingly, ultrastructural analysis of lysozyme-treated cells revealed morphological changes with or without the addition of salt. Damage appeared to occur at the blunted polar end of the cells where there was a large spherical outpouching bordered by a damaged cell envelope. Damaged cells uniformly contained dense granular cytoplasmic debris. In effect, the cationic enzyme lysed C. gingivalis 2010, which was not apparent in the spectrophotometric assay. The paradoxical finding that during bacterial aggregation there was lysis may be of significance to the further elucidation of lysozyme's antibacterial role in the gingival sulcus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967924      PMCID: PMC263192          DOI: 10.1128/iai.47.2.457-464.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Host responses in periodontal diseases.

Authors:  R J Genco; J Slots
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

2.  Suppression of murine lymphocyte mitogen responses by exopolysaccharide from Capnocytophaga ochracea.

Authors:  R W Bolton; J K Dyer
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Cell wall degradation of Staphylococcus aureus by lysozyme.

Authors:  J Wecke; M Lahav; I Ginsburg; P Giesbrecht
Journal:  Arch Microbiol       Date:  1982-03       Impact factor: 2.552

4.  Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva.

Authors:  M Tortosa; M I Cho; T J Wilkens; V J Iacono; J J Pollock
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Characterization of an inducible bacteriophage from a leukotoxic strain of Actinobacillus actinomycetemcomitans.

Authors:  R H Stevens; B F Hammond; C H Lai
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Quantitative recovery, selective removal and one-step purification of human parotid and leukemic lysozymes by immunoadsorption.

Authors:  B J MacKay; V J Iacono; J M Zuckerman; E F Osserman; J J Pollock
Journal:  Eur J Biochem       Date:  1982-12

7.  Adsorption of lysozyme from human whole saliva by Streptococcus sanguis 903 and other oral microorganisms.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Selective recovery of oral Capnocytophaga spp. with sheep blood agar containing bacitracin and polymyxin B.

Authors:  P A Mashimo; Y Yamamoto; M Nakamura; J Slots
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

9.  Endogenous pyrogen production by human blood monocytes stimulated by staphylococcal cell wall components.

Authors:  M M Oken; P K Peterson; B J Wilkinson
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens.

Authors:  M Kilian
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  7 in total

1.  Effect of lysozyme chloride on betel quid chewing aggravated gastric oxidative stress and hemorrhagic ulcer in diabetic rats.

Authors:  Chen-Road Hung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

2.  A role for the class A penicillin-binding protein PonA2 in the survival of Mycobacterium smegmatis under conditions of nonreplication.

Authors:  Maria-Magdalena Patru; Martin S Pavelka
Journal:  J Bacteriol       Date:  2010-04-16       Impact factor: 3.490

3.  Adherence of Streptococcus sanguis to hydroxyapatite coated with lysozyme and lysozyme-supplemented saliva.

Authors:  L M Tellefson; G R Germaine
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Effect of lysozyme on glucose fermentation, cytoplasmic pH, and intracellular potassium concentrations in Streptococcus mutans 10449.

Authors:  Y B Wang; G R Germaine
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

Review 5.  Antivirals against animal viruses.

Authors:  T G Villa; L Feijoo-Siota; J L R Rama; J M Ageitos
Journal:  Biochem Pharmacol       Date:  2016-09-30       Impact factor: 5.858

6.  "Click on the bidirectional switch": the aptasensor for simultaneous detection of lysozyme and ATP with high sensitivity and high selectivity.

Authors:  Feng Chen; Changqun Cai; Xiaoming Chen; Chunyan Chen
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

7.  Relationship between the nutritional status and antimicrobial protein levels with the periodontal condition in untreated head and neck cancer patients.

Authors:  Anu Anna John; Kumar C Naresh; V Ranganath; M Rao Subramaniam; Abhilasha S Patil; Puneet N Jumani
Journal:  J Family Med Prim Care       Date:  2019-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.